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Original Article
Characteristics of patients with Guillain Barre Syndrome at a tertiary care centre
in Pakistan, 1995-2003
Mohammad Yawar Yakoob1, Aisha Rahman1, Bushra Jamil2, Nadir Ali Syed1
Departments of Medicine1 and Pathology/Microbiology2, The Aga Khan University Hospital, Karachi, Pakistan.

Abstract
Objective: To study the clinical presentation, hospital course and outcome of patients admitted with Guillain
Barre Syndrome (GBS) to a tertiary care hospital in Karachi, Pakistan.
Methods: The charts of patients conforming to International Classification of Diseases (ICD) code 9.0, for GBS,
from September 1995 to January 2003 were reviewed. Clinical data was recorded on a standardized questionnaire, which included patients' age, sex, antecedent events, neurological signs and symptoms and ventilation
requirement. The hospital course was analyzed, including nosocomial infections, therapy given and the functional status of patients, using the Rankin scale (0-6). Standard SPSS 11.5 software (Windows) was used for data
analysis.
Results: Thirty-four cases of GBS were admitted to the hospital during the study period, with an age range of 3
to 70 years. The mean age for disease onset was 35.2 years for female patients, compared to 30 years for males;
the male/female ratio was 1.6:1.Gastrointestinal infections (12/22, 54.6%) were the most common antecedent
event, followed by upper respiratory tract infections (9/22, 40.9%) and skin lesions (1/22, 4.5%). Most patients
developed GBS within one month of the preceding infection. Cranial nerve abnormalities (30/34, 88.2%), autonomic dysfunction (21/34, 61.8%) and respiratory failure requiring intubation (19/34, 55.9%) were also common.
The median Rankin score of patients at admission, and at 30 and 60 days thereafter was 5, 4 and 3.5 respectively. The in-patient mortality was 1 of 34 (2.4%).
Conclusion: We found that GBS occurred at all ages and was slightly more common in males. Majority of
patients had an antecedent history of infection and had severe disease on presentation. The patients were treated with either plasmapheresis or intravenous immunoglobulins and there was no significant difference in outcome in the two groups. Despite severe persistent disability, in-hospital mortality was low
(JPMA 55:493;2005).

Introduction
Guillain Barre Syndrome (GBS) is the leading cause
of acute neuromuscular weakness in the developed world.1
Different terminologies e.g. acute inflammatory demyelinating polyneuropathy (AIDP), acute motor axonal neuropathy (AMAN), acute motor-sensory axonal neuropathy
(AMSAN) and Miller Fisher Syndrome, are all included
under the rubric of GBS.2
GBS leads to a wide variety of deficits, characterized
by rapidly evolving, symmetrical and often ascending limb
weakness, loss of deep tendon reflexes, variable sensory
signs and autonomic dysfunction.3 Occurring worldwide, it
affects people of all ages and both sexes. Studies on patients
with GBS indicate that the disease is the result of aberrant
immune responses against components of peripheral nerves.
Auto-reactive T-lymphocytes and antibodies against myelin
antigens (P0, P2), glycoproteins and glycolipids have been
identified.4 Other non-specific, pro-inflammatory mechanisms also contribute to nerve damage.4
The exact etiology of Guillain Barre Syndrome
remains elusive and incompletely defined. It is generally
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considered to be a post-infectious disease, with almost twothird of patients reporting an infectious illness prior to the
onset of symptoms.5
There is limited data on the characteristics of GBS in
Pakistan and the inpatient mortality is not established. The
purpose of this study was, therefore, to review the clinical
course and outcome of patients with Guillain Barre
Syndrome admitted to our hospital over a 9-year period
from 1995 to 2003. Special emphasis was laid on the treatment given and the complications which developed during
their hospital stay. The modified Rankin scale6 was used to
assess the functional status of patients on admission and at
days 30 and 60 of presentation to our hospital.

Patients and Methods
The study was carried out at the Aga Khan
University Hospital (AKUH), a 647-bed tertiary care referral centre in Karachi, Pakistan. The in-patient hospital
Meditech (Magic) system over a 9-year period (from 1995
to 2003) identified 41 patients who were admitted to AKUH
with the primary diagnosis of Guillain Barre Syndrome.
Records of seven patients were not accessible at the time of

493

data collection; therefore, the final number of patients
reviewed was 34. The final diagnosis of Guillain Barre
Syndrome in these patients was made on the basis of clinical presentation, CSF findings, electromyography and nerve
conduction studies.
A structured questionnaire was designed which
documented age of the patient, antecedent history of
infection, neurologic dysfunction and length of unit
intensive care (ICU) and hospital stay. Patients' records
were also used to note complications during hospital stay,
management, and the treatment given. Rankin scale (0-6)
was applied to assess the functional status of each patient
at the time of admission, and again at 30 and 60 days of
presentation. Clinical status on follow-up after day 60,
where available, was recorded. All information was
coded to retain patient confidentiality. Data collected was
entered and analyzed using SPSS 11.5 (Windows).
Fisher's Exact test was used to study the association
between the treatment given and the response of the
patient (at 30 and 60 days after the initial presentation).
A P-value of less than 0.05 was considered statistically
significant; the P-values were two-sided. Any change in
the Rankin score (towards zero) was considered an
improvement in the patient's condition.

Results
The study included 34 patients with GBS. The
mean (SD) age was 32 (19.9) years (range 3 to 70 years),
with ten (29.4%) patients less than 18 years of age. A
total of 21 (61.8%) patients were male, with a
male/female ratio of 1.6:1. Seasonal preponderance was
found, with 11 (32.4%) patients developing the disease in
spring (March to May), 11 (32.4%) in autumn
(September to November) and nine (26.5%) in winter
(December to February); seven (20.6%) patients presented in the month of October and five (14.7%) in the month
of March. The average duration of hospital stay was 25.7
days (SD 25.2, range 8 to 141 days).
Twenty-two (64.7%) patients reported a history of
infection within one month prior to onset of illness.
Gastrointestinal infections were the most common (12/22,
54.6%), followed by upper respiratory tract (9/22, 40.9%)
and skin infection (1/22, 4.5%). Sixteen (47.1%) of the 34
patients also had a concomitant history of fever.
All 34 patients had the initial symptoms of limb
weakness and inability to walk (unaided ataxia). Another
universal finding seen during the course of illness was
reduced or absent deep tendon reflexes (DTR). Twentythree (67.6%) patients had a Rankin score of 5 at admission, while nine (26.5%) had a score of 4, suggestive of
severe disease.
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Pain was the chief compliant in 26 (76.5%) of the 34
patients, the most common locations being the extremities
(13/26, 50%) and the back (11/26, 42.3%). Other locations
included the neck, chest, abdomen and shoulders, with three
(11.5%) patients complaining of a generalized ache of the
body. The frequency of other neurological signs and symptoms is shown in Table 1.
Table 1. Clinical features in 34 patients with GBS.
Clinical Features

Frequency

(%)

Sensory disturbance (numbness, dysthesias)

13/34

38.2

Cranial nerve involvement

30/34

88.2

Facial diaparesis

19/30

63.3

Dysphagia

15/30

50

Opthalmoplegia

7/30

23.3

Decreased gag reflex

6/30

20

Dysarthria

5/30

16.7

Ptosis

5/30

16.7

Deviated tongue

1/30

3.3

Difficulty shrugging shoulders

1/30

3.3

Slow reacting pupils

1/30

3.3

Respiratory failure requiring intubation

19/34

55.9

Autonomic dysfunction

21/34

61.8

Sinus tachycardia

10/21

47.6

Sinus bradycardia

3/21

14.3

Fluctuating B.P/ hypertension

16/21

76.2

Urinary dysfunction

6/21

28.6

Constipation

31/34

88.2

Table 2. Electromyographic (EMG) findings in patients with GBS.
Type of neuropathy

Frequency (%)

Demyelinating

14/34 (41.1)

Axonal

9/34 (26.4)

Undifferentiated

10/34 (29.4)

Unknown

1/34 (2.9)

The electromyographic and nerve conduction studies
(33/34 patients) showed that demyelinating type of neuropathy was the predominant form of GBS in our patients
(table 2). The mean cerebrospinal fluid glucose, protein and
total leukocyte count were 76.8 g/dL, 93.3 mg/dL and 4
respectively.
The average duration of stay in the ICU was 18.6
days (SD=21.1, range 3 to 124). The most common ICU
related complication seen was sepsis (n=14, 41.2%). Blood
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cultures were positive in 14 (41.1%) patients.
Staphylococcus aureus was the most common isolate
(35.7%). Nineteen (55.9%) patients had to be intubated
because of respiratory failure. Seventeen of the 19 intubated patients developed purulent respiratory secretions. Of
these, eight had chest X-ray findings suggestive of pneumonia. The commonest isolate from tracheal secretions was
Pseudomonas aeruginosa (41.2%) followed by
Staphylococcus aureus (35.3%), Streptococcus pneumoniae
(29.4%) and Hemophilus influenzae (23.5%). Eight of 34
patients (23.5%) developed bedsores during their hospital
stay and one patient developed deep venous thrombosis
(DVT) with subsequent pulmonary embolism.

aplastic anaemia following allogeneic hematopoietic stem
cell transplantation7, case series focusing on differential features of GBS (22 patients) and hypokalemic periodic paralysis8 and electrodiagnostic features in 40 patients with
GBS.9 None of the previous studies describe the clinical
features in addition to electrodiagnostic findings of GBS in
Pakistani population. In the current study we collected data
on GBS patients who were admitted to our hospital from
1995 to 2003.
In accordance with most Western and Asian studies,
GBS was more common in the adult age group (>18 year,
n=24, 70.6%). The male to female ratio of 1.6:1 in our
patients was similar to that cited in other studies.2,10-12

The median Rankin score at the time of admission
was 5, which decreased to 4 and 3.5 at 30 and 60 days of
admission respectively (Figure). Majority of the patients
exhibited a good recovery during the weeks following the
hospital admission. In addition to supportive care, all 34
patients received specific treatment for GBS: 20 patients
(58.8%) were managed with plasmapharesis, 12 (35.3%)
received intravenous immunoglobulins (IVIG) and 2 patients
were managed with sequential plasmapheresis and IVIG. A
higher proportion of patients treated with plasmapheresis
showed improvement at day 30 of presentation, compared to
those who received intravenous immunoglobulins (P=0.418)
with a similar trend at day 60 of presentation (P=1.000).
Twenty three patients (74.2%) showed significant recovery at
day 30. The rest of the patients continued to improve subsequently and only 2 patients (7.4%) remained with severe disability by day 60 of presentation. Only one patient died of
cardiac arrest during admission to the hospital.

Though seasonal trends were not seen in most
series13-15, a few report seasonal clustering in the autumn
and winter months.16,17 According to two studies conducted in Taiwan, one found seasonal preponderance in winter11, while the other found it to be in spring.12 In our
study, we had a seasonal clustering in spring (MarchMay), autumn (September-November) and winter
(December-February). Only three patients in our series
presented in summer (June to August).

30

mber of patients

25

Most studies showed an antecedent history of
infection in 50 to 71% of patients with GBS.2,10-12,18 This
is comparable to our findings. In most studies, non-specific upper respiratory tract infection was the most common
preceding event2,10-12,19 in contrast to our patients in whom
history of preceding gastrointestinal infections was more
frequent. The higher frequency of gastrointestinal infections in our series could probably be related to the higher
prevalence of gut pathogens and poor hygienic standards
in our part of the world as compared with the developed
world.20
Occurrence of autonomic dysfunction in our patients
was similar to that shown by various Chinese, Taiwanese
and American studies.2,10-12,19 Pain was an extremely common complaint in our patients (76.5%); this is much higher
than that cited (13.8%) in another study.12

23

In our study, cranial nerve involvement was seen in
88.2% of patients, which is similar to that reported by
Cheng18 and Mckhann.19

20

14

15

Figure. The Rankin score of patients at admission and at 30 and 60 days.

Discussion
Guillain Barre Syndrome (GBS) is a relatively common cause of neuromuscular weakness. Unfortunately,
there is a paucity of published information on local incidence of the condition. Some of these are GBS in a case of
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Drowsiness and confusion during the early stage of
the illness has been reported21, along with ophthalmological
signs of central origin such as mild ptosis, paralysis of
upward gaze and horizontal dissociated nystagmus.22,23
However, recent reviews suggest that patients with various
eye movement disorders can be explained by cranial nerve
involvement alone13, and those patients who were drowsy
initially, might have a disorder other than GBS.24 None of
our patients had confusion or signs and symptoms suggestive of encephalopathy.
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The average duration of hospital stay in our patients
was 25.7 days (range 8-141 days), which is comparable to
that previously reported.12 The number of patients requiring ventilatory assistance was higher in our study (55.9%)
as compared to 21% to 43.1% reported in the literature.3,5,10
Similarly, sepsis was much more common in our patients
than that reported in other studies.11,12,18 This may be related to the referral of the more seriously ill patients to our
tertiary care facility. Ventilator-associated and intensive
care-related complications also contributed to the high incidence of sepsis.
Almost all our patients had a Rankin score of 4 or
5 at initial admission and none of the patients presented
with mild disease. This may be because of late presentation, late recognition or rapid progression of disease. The
disease itself may be more severe and/or rapidly progressive in our population. Again, a referral bias may account
for this finding.
Most of our patients had started recovering at the
time of discharge, although this is not evident from the
Rankin score at discharge. However, the patients were
regaining their motor and neurological functions on clinical
assessment. The mortality in our series is low (2.4%), which
is comparable with that in another series.12 Indefinite confinement to bed and/or prolonged ventilator dependence
was seen in a few of our patients who eventually recovered.
Most of our patients had demyelinating neuropathy.
However, fewer patients (42.4%) had demyelination as
compared with 82.5% of cases due to demyelinating
polyneuropathy reported in another Pakistani study.9 All our
patients who had prolonged recovery had either axonal or
undifferentiated EMG changes.

Conclusion
In conclusion, GBS was seen in all age groups.
Majority of the patients had an antecedent history of gastrointestinal infection. Rapid progression, severe disease
necessitating ventilation, prolonged hospital stay and slow
recovery were seen in most patients. There was no significant difference in disease outcome in patients treated with
either plasmapheresis or intravenous immunoglobulins. Inpatient mortality was low and severe disease on presentation
followed by protracted recovery was not associated with
poor outcome.
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